Lorillard
Testimony of Robert M. Daugherty, Jr., M. D., Ph.D. Chairman Subcommittee on Smoking American Heart Association Before the Subcommittee on Human Resources United States Senate
Fields
- Author
- Daugherty, R.M., J.R.
- Type
- TRAN, TRANSCRIPT
- BIBL, BIBLIOGRAPHY
- Area
- LEGAL DEPT FILE ROOM
- Litigation
- Feda/Produced
- Site
- N14
- Master ID
- 03603272/4564
Related Documents:- 03603272 Legislation Senator Kennedy's Bill S.3115 - Disease Prevention Health Promotion Legislation Volume I - 780525 -- 780615
- 03603273
- 03603274
- 03603275
- 03603276 Senator Edward M. Kennedy Announces Hearings on the National Disease Prevention and Health Promotion Act of 780000
- 03603277-3278 Opening Statement of Senator Edward M. Kennedy on 780607 at A Hearing on the National Disease Prevention and Health Promotion Act of 780000
- 03603279-3303 Statement by J. Michael Mcginnis, M.D. Deputy Assistant Secretary for Health (Special Health Initiatives) Before the Subcommitee on Health and Scientific Research Committee on Human Resources United States Senate
- 03603304-3311 Public Service Advertising and Health Information
- 03603312-3323 Statement of Charles B. Arnold M.D. M.P.H President of the American College of Preventive Medicine on S. 3115, the Disease Prevention and Health Promotion Act of 780000
- 03603324-3330 Testimony of Jonathan E. Fielding, M.D. Commissioner of Public Health Commonwealth of Massachusetts for the Association of State and Territorial Health Officials and the Commowealth of Massachusetts Before the Subcommittee on Health & Scientific Research Committee on Human Resources U.S. Senate
- 03603331-3339 Statement of the American Medical Association to the Subcommittee on Health and Scientific Research Commitee on Human Resources
- 03603340 Immunization Program - Draft Legislation
- 03603341-3344 A Bill to Provide for the Immunization of Children Against Major Infectious Diseases
- 03603345
- 03603346-3347 Carbon Monoxide Content of Cigarette Smoke to Be Published
- 03603348
- 03603349-3351 Statement of the American Lung Association on Title in of S. 3115 to the Senate Subcommittee on Health and Scientific Research Presented by Donald A. Young, M.D.
- 03603350 Untitled Document 03603350
- 03603352-3354 Statement by Senator Wendell H. Ford Senate Subcommittee on Health & Science Research Re: Anti-Smoking Legislation
- 03603355-3356 Opening Statement of Senator Eward M. Kennedy at A Hearing on Deterring Childhood Smoking
- 03603357-3359 Special Report Kennedy Hearing Supplement to Tobacco Institute Newsletter 199 780530
- 03603360-3365 Testimony of Lasalle D. Leffall, Jr., M.D. President-Elect, American Cancer Society Before the Health Subcommittee of the Senate Human Resources Committee
- 03603371-3375 Testimony Presented Before the Senate Subcommittee on Health and Scientific Research on 780525, Concerning the National Disease Prevention and Health Promotion Act of 780000
- 03603376-3383 Summary of Testimony to Be Presented to the United States Senate Sub-Committee on Health on 780525
- 03603384-3515 United States Senate Transcript of Proceedings Subcommittee on Health and Scientific Research Committee on Human Resources Hearing on Deterring Childhood Smoking
- 03603516
- 03603517-3529 S.3118 to Create Programs Designed to Promote Health Through Smoking Deterrence.
- 03603530-3531
- 03603532-3533 Senator Edward M. Kennedy Announces Hearing on Deterring Childhood Smoking
- 03603534-3535 Opening Statement of Senator Edward M, Kennedy at A Hearing on Deterring Childhood Smoking
- 03603536-3538 Statement by Senator Wendell H. Ford Senate Subcommittee on Health & Science Research Re: Anti-Smoking Legislation 780525
- 03603539-3556 Statement by William H. Foege, M.D. Director, Center for Disease Control Before the Subcommittee on Health and Scientific Research Committee on Human Resources United States Senate
- 03603557-3564 Summary of Testimony to Be Presented to the United States Senate Sub-Committee on Health on 780525
- 03603565-3569 Testimony Presented Before the Senate Subcommitte on Health and Scientific Research on 780525, Concerning the National Disease Prevention and Health Promotion Act of 1978
- 03603570-3576 Testimony of Lasalle D. Leffall, Jr., M.D. President-Elect, American Cancer Society Before the Health Subcommittee of the Senate Human Resources Committee
- 03603577-3579 Statement of the American Lung Association on Title IV of S. 3115 to the Senate Subcommittee on Health and Scientific Research Presented by Donald A. Young, M.D.
- 03603580-3584 Testimony of Robert M. Daugherty, Jr., M.D., Ph.D. Chairman Subcommittee on Smoking American Heart Association Before the Subcommittee on Health and Scientific Research Committee on Human Resources United States Senate 780525
- 03603585 Back Up Witness List
- 03603586-3591 National Bulletin
- 03603592-3613 Congressional Record - Senate 780519
- 03603614-4564 Disease Prevention and Health Promotion Act of 780000 Subcommittee on Health and Slientific Research of the Committee on Human Resources United States Senate S. 3115
- Named Organization
- American Heart Assn
- Comm on Human Resources
- Hew, Dept of Health Education and Welfare
- Subcomm on Health + Scientific Rese
- Subcommittee on Smoking
- Univ of Wy
- Comm on Human Resources
- Request
- R1-038
- Named Person
- Surgeon General
- Date Loaded
- 19 Dec 2001
- UCSF Legacy ID
- zhr88c00
Document Images
TESTIMONY
OF
ROBERT M. DAUGHfRTY,, 1R:, M.D., Ph..D.
CHAIRMAN
SUBCOMMITTEE ON,SMOKING
AMERICAN.HEART AS80CIATION
Before the
SUBCOMMITTEE ON HEALTH AND SCIENTIFIC RESEARCH
COMMITTEE ON HUMAN RESOURCES .
UNITED STATES SENATE
MAY' 25, 1978

13. Evans RI; Smoki'ng in Children: Developing a Social-Psychollogicall
Strategy of Deterrence. J. Prew. Med. 5: 12'2-1'27 1976.
4.

C
consequences from cigarette smoki.ng. Therefore, we support the following
proposed initiatives:
1. The i'nstitution of a di~fferential': federal tax oni ci~g,arettes accordiing
to their tar and nicotine content. Since the current trend among
smokers is to purchase lower tar and nicotine cigarettes (12), such
a system wouldi not only aid smokers in selecting a less hazardous
cigarette but would provide a financial'. incentive for them to, do so.
2. Utilizing the strongest possible statement.regarding the health risks
of smoking,,consistent with scientific evidence, as a warning label
to be placed.on cigarette packs., This could include the "°revol,ving
label""' which ilss being used in Sweden.
3.Support for epidemiolog,ilcal studiies.to determine the relative risks
associated with the varying levels of tar and ni~cotine and other.sub-
stances commonly added to commerically prepared.cigarettes. Continued
biomedical research i's needed to gain a better undprstanding.of the
mechanism through which cigarette,smoking contributes to the develop-
ment of cardiovas.cular disease.
4. The establishment of programs. designedto deter smoking among children
and adolescents. Since the onset of smoki'.ng,, specifically "experimental'
smoking"', is occurring at increasina7y earlier ages (13), this initi-
ative is right on target. As smoking continues to decline in the adult
population, there is a growth. in the number of smokers am,ong this
nation's youth, es~pecialily teenage girls. Therefore, we are partil-
cularily pleased to see the special emphasis om pre-teens and teen-
agers,.
A revisw, of th.e evidence to date linkingici'garettesi to coronary heart
disease peripheral arterial disease and chronic obstructive,pul~monary
disease indicates that smoking is a major and preventable cause of each of
these diseases. Gains against this man-made hazard have been modest
consi'deriing the vilgorous and effective actions being taken against other
man made environmental hazards, often based on less evidence of adverse
health consequences. Effective actfon is cleariy required.
The American Heart Association stands. ready to assiist this Subcommittee
and the Department of Health, Education and Welfare in your efforts to
improve the health of this nation. - - . 9.
Thank you.

1'.. The Health Consequences of Smoking. U.S. Department of Health, Educati'on
and Welfare. PHS, CDC, US Government Printing Office, 1975.
2. Kanneli WB',, Shurtleff D; The Framingtiam Study: Cigarettes and the Dev-
elopment of Intermittent Claudication. Geriatrics 28:61-68, 1973.
3. Fei',nlieb M, Williams RR;, Relative Risks of Myocardial Infarction,
Cardiovascullar Diseas.e and Peripherial Vascular Disease by Type of
Smokin~g. In Proceedings of the 3rd Worl,d Conference on Smoking and,
Health, 1975, .p.2,43. -
4. Hammond EC, Horn~ D; Smoking and Death Rates - Report on 44 Months of:ollow-up of 187,783 Men:I.
Total, Mortality. JAMA 166:1159-1172, 1958.
II. Death Rates. By Cause. pp., 1294-1i308'.
5. Kahn HA, The Do:rni Study ofSmoking and Mortality Ahiong, US Veterans.,
Report on 8ll years, of Observation in Epidemiologi'calStudy of Cancer and
Other Chronic Diseases. W. Haenszel, Edl. National Cancer Institute, ;
Monograph 19: 1-125, 1966.
6. Doll R, Hill AB; Mortality in Relation to Sinokingi: Ten Years Observations
of British Doctors. Brit. Ji. Med. 1:1399-1410; 1460-1476, 1964.
7. Proceedings of the 3rd World!Conference on Smoking and Healtth, 1975.
Vol. 1: Modifying the Risk for the Smoker. US Department of Health,.
Education and Welfare. PHS,,NIH, (DHEW Publ. No.(NS.H). 76-1221).
8. Gordon T, Kannel' WB, McGee D; Death, and Coronary Attacks in Men After
Giving up Cigarette Smoking. Report from,the Framingham Study.
, Lancet 2':1345-1'353, 1974.
9'. Aronow WS, Kaplan MA', Jacob D:; Tobacco: A Precipitating Factor in
Angina Pectoris. Ann. Intern. Med. 69:529-539,,1968.
10. Astrup P, Kjel:ldsen K, W'anstrup P; Enhanciing Influence of Carbon Mbnoxide
on the Development of Atheromatosils in Chol'esterol-fed Rabbits. J.
Atherosc]erosis Res. 7: 343-354,. 1967. . #6
11. Shurtlleff D. Some Characteristics Related to. the.Incidence of Cardio-
vascular Disease and' Death; The Framingham,Study, 18 Years Fol'low-up..
DHEW Publ. (NIH.) No. 74-599-1974..
W
12. A National Dilemma: Cigarette Smoking or the Health of Americans.,
Report of the National Commission on S.noking and,Public Policy to ~
the Board ofDirectors, American Cancer Society, January 31, 1978. O,
w

Mr. Chairman and' members of the Subcommfttee, my name is Robert M. Daugherty,
Jr. , M.D., Ph.D. I am presently the Dean. of the Mediicall School at the
University of Wyomingiand!Chairman of the Subcommittee on Smoking of the
American Heart Association.
Althoughi the smoker can reduce the health risks of smoking by smoking fewer
cigarettes, switching, to filltered low tar and nicotine cilgareti:es., taking
fewer puffs and not inhaling, the only sure way is to abstain from smokfng
serious j'eopardy (11).
chronic bronchitis and emphysema, diseases whilch are in turn the chi'ef
causes of pulmonary heart,disease and aggravate other types of heart
disease. The risk of'cardiovascul,ar di.sease increases in proportion to
the number of cigarettes smoked and-the duration of exposure to the habit.
The effect of cigarette smoking on cardi~ovascular disease risk i's inde-
pendent of the other maj,or risk factors and; the risk is greatly aggravated
when such: factors as high blood pressure, high.bloodicholesterol or di,abetes ,~
are present. Such hilgh risk persons who also smoke place themselves iln `
i pheral arterial disease (2)'. Smoking is also the principal cause of both
American Heart Association is a non-profit voluntary health organization
consisting of some 40',,000 scientists, 65,000 other key membersand some =
2,000,000 citizen volunteers who are dedicated to the reduction of pre-
mature death, and disability resulting from cardiovascular disease.
Cigarette smoking has been held,responsible for many thousandsof prema-
ture deaths eacli,year. Total mortality is twice as high among cigarette
smokers as among, nonsmokers., Many of these smokers d'ie of'coronary heart
disease. In fact, cigarette smoking greatly increases an individual's
risk of developing cardiovascular disease.
Since the first Surgeon General's Report on Smoking in 1964, the contri- ;
but:Aon of'cigarette smoking to the dlevelopment of'heart attack and coro-
n:.~;~ ti_-:rt disease mortality has been further confirned and strengthened
by additional' epidemiological, clinical and anatomical evi'dence (1-7).
Cigarette smokiing has now been firmly connected with.th.e onset of peri-
I appreciate the,opportunity to appear before this SubcomniiteQ o:n behalf'
of the American Heart Association to testify in support of the National
Disease Prevention and Health Promotion Act of 1978. As you may know, the
entirely. A shift to ci'gar and pipe smoking i's not effective if the
former cigarette smoker continues to inhale (3).,
O
In vi:ew of the evidence linking cigarette smoking to card5ovascutar disease o
which I have summarized'r for you, the Ameri'can, Heart Association applauds 0
W
you, Mr. Chairman, for introducing legislation aimed at reducing,the health W
°
~-
